Differences in gastric cancer survival between the U.S. and China

Journal of Surgical Oncology

Volumn 112, Issue 1, 2015, Pages 31-37

  Strong, Vivian E ^a   Wu, Ai Wen ^b   Selby, Luke V ^a   Gonen, Mithat ^a   Hsu, Meier ^a   Song, Kyo Young ^c   Park, Cho Hyun ^c   Coit, Daniel G ^a   Ji, Jia Fu ^b   Brennan, Murray F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c The Catholic University of Korea   (South Korea)

Author keywords

gastrectomy; gastric cancer

Indexed keywords

FLUOROURACIL DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHINA; CHINESE; FEMALE; GASTRECTOMY; HIGH VOLUME HOSPITAL; HUMAN; LYMPH NODE METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; STOMACH CANCER; SURGICAL PATIENT; TREATMENT OUTCOME; UNITED STATES; ADENOCARCINOMA; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHINA; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84937394048     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23940     Document Type: Article

References (36)

1. World Health Organization: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012. In.
2. Strong VE, Song KY, Park CH, et al.,: Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma. J Surg Oncol 2013; 107: 634-640.
3. Strong VE, Song KY, Park CH, et al.,: Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010; 251: 640-646.
4. Noguchi Y, Yoshikawa T, Tsuburaya A, et al.,: Is gastric carcinoma different between Japan and the United States? Cancer 2000; 89: 2237-2246.
5. Bollschweiler E, Boettcher K, Hoelscher AH, et al.,: Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer 1993; 71: 2918-2925.
6. Gray RJ,: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
7. Kattan MW, Karpeh MS, Mazumdar M, et al.,: Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 2003; 21: 3647-3650.
8. Selby LV, Vertosick EA, Sjoberg DD, et al.,: Morbidity after total gastrectomy: Analysis of 238 patients. J Am Coll Surg 2015.
9. Liu Y, Kaneko S, Sobue T,: Trends in reported incidences of gastric cancer by tumour location, from 1975 to 1989 in Japan. Int J Epidemiol 2004; 33: 808-815.
10. Ahn HS, Lee HJ, Yoo MW, et al.,: Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period. Br J Surg 2011; 98: 255-260.
11. Chen W, Zhang S, Chen Z,: An epidemiologic trend analysis on cardiac cancer in high incidence areas of esophageal cancer and gastric cancer in China. China Cancer 2008; 17: 998-1000.
12. Zhang X, Huang C, Lu H,: Clinical observation of surgical treatment and prognosis in gastric cancer. Chin Med J 2002; 82: 1142-1143.
13. Chen L, Zhang Y, Wei B, et al.,: [Surgical treatment for patients with gastric cancer: Report of 2335 cases]. Zhonghua wei chang wai ke za zhi = Chin J Gastrointest Surg 2007; 10: 421-424.
14. Wu A-w, Ji J-f, Yang H, et al.,: Long-term outcome of a large series of gastric cancer patients in China. Chin J Cancer Res 2010; 22: 167-175.
15. Qiao YL, Dawsey SM, Kamangar F, et al.,: Total and cancer mortality after supplementation with vitamins and minerals: Follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 2009; 101: 507-518.
16. Blot WJ, Devesa SS, Kneller RW, et al.,: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. Jama 1991; 265: 1287-1289.
17. Lagergren J, Bergstrom R, Nyren O,: Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 883-+.
18. Pera M, Cameron AJ, Trastek VF, et al.,: Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510-513.
19. Souza RF, Spechler SJ,: Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA: Cancer J Clin 2005; 55: 334-351.
20. Abnet CC, Freedman ND, Hu N, et al.,: A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010; 42: 764-767.
21. Wang LD, Zhou FY, Li XM, et al.,: Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010; 42: 759-763.
22. Ji CY, Sun JL, Chen TJ,: [Dynamic analysis on the prevalence of obesity and overweight school-age children and adolescents in recent 15 years in China]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2004; 25: 103-108.
23. Redaniel MT, Laudico A, Mirasol-Lumague MR, et al.,: Cancer survival discrepancies in developed and developing countries: Comparisons between the Philippines and the United States. Br J Cancer 2009; 100: 858-862.
24. Kuwahara A, Takachi R, Tsubono Y, et al.,: Socioeconomic status and gastric cancer survival in Japan. Gastric Cancer 2010; 13: 222-230.
25. Shiu MH, Moore E, Sanders M, et al.,: Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis. Arch Surg 1987; 122: 1347-1351.
26. Harrison LE, Karpeh MS, Brennan MF,: Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998; 123: 127-130.
27. Barbour AP, Rizk NP, Gonen M, et al.,: Adenocarcinoma of the gastroesophageal junction: Influence of esophageal resection margin and operative approach on outcome. Ann Surg 2007; 246: 1-8.
28. Morales TG,: Adenocarcinoma of the gastric cardia. Dig Dis 1997; 15: 346-356.
29. Sasako M, Sano T, Yamamoto S, et al.,: Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: A randomised controlled trial. Lancet Oncol 2006; 7: 644-651.
30. McCulloch P, Taggart T, Ochiai A, et al.,: c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol 1997; 23: 304-309.
31. Davis PA, Sano T,: The difference in gastric cancer between Japan, USA and Europe: What are the facts? what are the suggestions? Crit Rev Oncol/Hematol 2001; 40: 77-94.
32. Hundahl SA, Stemmermann GN, Oishi A,: Racial factors cannot explain superior Japanese outcomes in stomach cancer. Arch Surg 1996; 131: 170-175.
33. Livingstone JI, Yasui W, Tahara E, et al.,: Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. Br J Cancer 1995; 72: 976-980.
34. Kwong SL, Chen MS, Jr., Snipes KP, et al.,: Asian subgroups and cancer incidence and mortality rates in California. Cancer 2005; 104: 2975-2981.
35. Hundahl S, Phillips J, Menck H,: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 2000; 88: 921-932.
36. You WC, Li JY, Zhang L, et al.,: Etiology and prevention of gastric cancer: A population study in a high risk area of China. Chin J Dig Dis 2005; 6: 149-154.